Replimune (REPL) had the highest return between May 28, 2024 and June 13, 2024 by a small-cap US stock, returning 78.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Replimune (REPL) | 5/28/2024 - 6/13/2024 | 78.49% |
Advent Technologies (ADNWW) | 5/28/2024 - 6/13/2024 | 58% |
Forward Air (FWRD) | 5/28/2024 - 6/13/2024 | 55.66% |
Semler Scientific (SMLR) | 5/28/2024 - 6/13/2024 | 53.28% |
Jumia Technologies (JMIA) | 5/28/2024 - 6/13/2024 | 53.07% |
Stitch Fix (SFIX) | 5/28/2024 - 6/13/2024 | 51.71% |
Rezolute (RZLT) | 5/28/2024 - 6/13/2024 | 42.54% |
Nano Nuclear Energy Inc Common Stock (NNE) | 5/28/2024 - 6/13/2024 | 41.97% |
Geron (GERN) | 5/28/2024 - 6/13/2024 | 40.63% |
Structure Therapeutics Inc American Depositary Shares (GPCR) | 5/28/2024 - 6/13/2024 | 38.37% |
Larimar Therapeutics (LRMR) | 5/28/2024 - 6/13/2024 | 36.67% |
Olema Pharmaceuticals (OLMA) | 5/28/2024 - 6/13/2024 | 35.58% |
Flotek Industries (FTK) | 5/28/2024 - 6/13/2024 | 35.28% |
Esperion Therapeutics (ESPR) | 5/28/2024 - 6/13/2024 | 34.72% |
UroGen Pharma (URGN) | 5/28/2024 - 6/13/2024 | 34.62% |
Know Labs (KNW) | 5/28/2024 - 6/13/2024 | 32.87% |
Eos Energy Enterprises (EOSE) | 5/28/2024 - 6/13/2024 | 31.68% |
Terns Pharmaceuticals (TERN) | 5/28/2024 - 6/13/2024 | 31.03% |
Redwire (RDW) | 5/28/2024 - 6/13/2024 | 29.53% |
Taysha Gene Therapies (TSHA) | 5/28/2024 - 6/13/2024 | 28.7% |
Rapport Therapeutics, Inc Common Stock (RAPP) | 5/28/2024 - 6/13/2024 | 28.06% |
Bitfarms (BITF) | 5/28/2024 - 6/13/2024 | 27.73% |
Rackspace Technology (RXT) | 5/28/2024 - 6/13/2024 | 27.32% |
Neogen (NEOG) | 5/28/2024 - 6/13/2024 | 26.6% |
Emergent Biosolutions (EBS) | 5/28/2024 - 6/13/2024 | 26.1% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
